TapewireFind a company

person · Reporting owner

McGroddy-Goetz Kathleen

Disclosed activity across 1 company

Tapewire entity
44765
SEC CIK
0001814371

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TANDEM DIABETES CARE INCTNDM · Entity 4682DirectorMay 20, 2026May 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TANDEM DIABETES CARE INC

Report date May 20, 2026 · Filed May 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect26,612 Reported balance After 2026-05-21 transaction · row 1
1 source row

Row 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 26,612

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect10,220 Reported balance After 2026-05-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-05-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2026 Filed May 22, 2026 20:07 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 8,759 $0.00 $0.00
Disclosure

SEC source: 0001438133-26-000075 · wk-form4_1779480468.xml · derivative · entry 3

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,759 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F3 · derivative.exercise_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

F3 · derivative.expiration_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:07 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 8,759 $0.00 $0.00
Disclosure

SEC source: 0001438133-26-000075 · wk-form4_1779480468.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,612

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2026 Filed May 22, 2026 20:07 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 10,220 $0.00 $0.00
Disclosure

SEC source: 0001438133-26-000075 · wk-form4_1779480468.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,220

Underlying: Common Stock · 10,220 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2 · derivative.exercise_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

F2 · derivative.expiration_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:03 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 4,387 $0.00 $0.00
Disclosure

SEC source: 0001438133-25-000108 · wk-form4_1748030627.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,387 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:03 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 4,387 $20.64 $90,547.68
Disclosure

SEC source: 0001438133-25-000108 · wk-form4_1748030627.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2025 Filed May 23, 2025 20:03 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 8,759 $0.00 $0.00
Disclosure

SEC source: 0001438133-25-000108 · wk-form4_1748030627.xml · derivative · entry 3

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,759

Underlying: Common Stock · 8,759 shares

Expires not disclosed

F4 · security: Awarded on May 21, 2025 pursuant to the 2023 Plan.

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 24, 2024 Filed May 24, 2024 23:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 4,434 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000124 · wk-form4_1716592941.xml · derivative · entry 3

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Awarded on May 24, 2023 pursuant to the 2023 Plan.

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 24, 2024 Filed May 24, 2024 23:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 4,434 $51.73 $229,370.82
Disclosure

SEC source: 0001438133-24-000124 · wk-form4_1716592941.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 4,387 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000124 · wk-form4_1716592941.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,387

Underlying: Common Stock · 4,387 shares

Expires not disclosed

F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 20:20 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 PurchaseCommon Stock 1,000 $21.45 $21,450.00
Disclosure

SEC source: 0001438133-23-000197 · wk-form4_1695154829.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,032

Read SEC document
June 08, 2023 Filed Jun 12, 2023 20:01 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 1,220 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000135 · wk-form4_1686600098.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on June 6, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 20:01 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,220 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000135 · wk-form4_1686600098.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2023 Filed May 26, 2023 20:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 2,757 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000107 · wf-form4_168513180181675.xml · derivative · entry 3

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,757 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
May 25, 2023 Filed May 26, 2023 20:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 2,757 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000107 · wf-form4_168513180181675.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 26, 2023 20:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRSU 2023 05 24 · Derivative 4,434 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000107 · wf-form4_168513180181675.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,434

Underlying: Common Stock · 4,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 1,220 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000158 · wf-form4_165489461735779.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,220

Underlying: Common Stock · 1,220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSUs granted on 6/8/2020 vest over a period of three years in equal annual installments on the anniversary of the grant.

F3 · derivative.expiration_date: RSUs granted on 6/8/2020 vest over a period of three years in equal annual installments on the anniversary of the grant.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,220 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000158 · wf-form4_165489461735779.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2022 Filed May 28, 2022 01:44 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 2,757 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000119 · wf-form4_165370224905653.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,757

Underlying: Common Stock · 2,757 shares

Expires not disclosed

F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
May 18, 2022 Filed May 20, 2022 00:05 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 2,021 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000099 · wf-form4_165300513349400.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,021 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
May 18, 2022 Filed May 20, 2022 00:05 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 2,021 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000099 · wf-form4_165300513349400.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 21:02 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 405 $106.00 $42,930.00
Disclosure

SEC source: 0001438133-22-000039 · wf-form4_164746452290623.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 814

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:56 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 1,219 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000095 · wf-form4_162335860091572.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,440

Underlying: Common Stock · 1,219 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F3 · kind: This RSU award was granted on June 8, 2020. 33% of the RSU vested on June 8, 2021 and the remaining 67% will vest annually over the next two years.

F4 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:56 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,219 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000095 · wf-form4_162335860091572.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 18, 2021 Filed May 21, 2021 01:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 2,021 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000038 · wf-form4_162155929717471.xml · derivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,021

Underlying: Common Stock · 2,021 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 20:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 3,659 $0.00 $0.00
Disclosure

SEC source: 0001438133-20-000092 · wf-form4_159182108134419.xml · derivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,659

Underlying: Common Stock · 3,659 shares

Expires not disclosed

F1 · security: Awarded on June 8, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.